Coronary Restenosis
📧 Sign up to get email alerts when something new happens for Coronary Restenosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-02-03Clinical Trial Update: Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents [NA]
A clinical trial update comparing the bioresorbable polymer Orsiro stent to the durable polymer Resolute Onyx stent in patients with coronar…
-
CLINICAL_TRIALS research · 2017-02-03Clinical Trial Update: DUrable Polymer-based STent CHallenge of Promus ElemEnt Versus ReSolute Integrity [NA]
A clinical trial update comparing the Promus Element versus Resolute Integrity drug-eluting stents in coronary artery disease, with the tria…
-
CLINICAL_TRIALS trial_result · 2016-12-09Clinical Trial Update: ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease
A postmarketing surveillance registry assessing the safety and performance of the everolimus-eluting bioresorbable vascular scaffold in pati…
-
CLINICAL_TRIALS trial_result · 2016-11-21Clinical Trial Update: Efficacy Study of Paclitaxel-eluting Balloon, -Stent vs. Plain Angioplasty for Drug-eluting Stent Restenosis [Phase 4]
Phase 4 efficacy study comparing paclitaxel-eluting balloon and paclitaxel-eluting stent versus plain angioplasty for restenosis after drug-…
-
CLINICAL_TRIALS trial_result · 2016-08-24Clinical Trial Update: XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval Randomized Control Trial (RCT) [Phase 4]
Phase 4 post-approval randomized trial in China evaluating the XIENCE V Everolimus-eluting coronary stent system was completed, with results…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-08-05Clinical Trial Update: The Effects of Bindarit in Preventing Stent Restenosis [Phase 2]
Phase 2 trial evaluating Bindarit to prevent restenosis after coronary stent placement has completed.
-
CLINICAL_TRIALS trial_result · 2016-06-28Clinical Trial Update: XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort [Phase 4]
Phase 4 clinical trial update for XIENCE V USA Dual Antiplatelet Therapy cohort; study completed with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-02-01Clinical Trial Update: Long Term Safety Profile of the PRO-Kinetic ENERGY Coronary Stent System in Daily Clinical Practice
Long-term safety data for the PRO-Kinetic ENERGY Coronary Stent System in daily clinical practice are summarized. The update focuses on safe…
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Per-cutaneous Intervention Based Paclitaxel and Sirolimus-Eluting Versus Bare Stents for the Treatment of de Novo Coronary Lesions (PAINT) [Phase 4]
Phase 4 trial comparing paclitaxel-eluting and sirolimus-eluting stents against bare stents for de novo coronary lesions; the study is compl…
-
CLINICAL_TRIALS trial_result · 2015-07-28Clinical Trial Update: DUrable Polymer-based STent CHallenge of Promus Element Versus ReSolute Integrity in an All Comers Population [Phase 4]
Phase 4 trial comparing Promus Element (everolimus-eluting) and Resolute Integrity (zotarolimus-eluting) durable-polymer stents in an all-co…
-
CLINICAL_TRIALS trial_result · 2015-07-28Clinical Trial Update: The Real-World Endeavor Resolute Versus XIENCE V Drug-Eluting Stent Study in Twente [Phase 4]
Phase 4 real-world trial comparing Resolute and XIENCE V drug-eluting stents in Twente has completed. The study evaluated outcomes in patien…
-
CLINICAL_TRIALS trial_result · 2015-05-13Clinical Trial Update: XIENCE V: SPIRIT WOMEN [Phase 4]
This is a Phase 4 clinical trial update for XIENCE V in the SPIRIT WOMEN study, which has completed. The trial evaluated outcomes of the XIE…
-
CLINICAL_TRIALS trial_result · 2015-02-06Clinical Trial Update: The ASSURE ROT Registry: Bioresorbable Vascular Scaffold Following Rotablation for Complex Coronary Lesions
This is a ClinicalTrials.gov registry entry for the ASSURE ROT Registry evaluating a bioresorbable vascular scaffold after rotablation for c…
-
CLINICAL_TRIALS trial_result · 2014-10-13Clinical Trial Update: EGO-COMBO Clinical End-point Extension Study Beyond 36 Months
Clinical trial update indicates the EGO-COMBO endpoint extension study for coronary restenosis has extended beyond 36 months and is reported…
-
CLINICAL_TRIALS trial_result · 2014-01-03Clinical Trial Update: A Clinical Evaluation of the XIENCE PRIME Small Vessel Everolimus Eluting Coronary Stent System in Japanese Population [NA]
A completed clinical trial evaluated the XIENCE PRIME Small Vessel Everolimus Eluting Coronary Stent System in a Japanese population. Result…
-
CLINICAL_TRIALS trial_result · 2013-10-11Clinical Trial Update: XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA Long Term Follow-up Cohort)
This is a USA post-approval long-term follow-up study of the XIENCE V everolimus-eluting coronary stent system; results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: OCT Evaluation of Healing of COMBO Stent [Phase 1, Phase 2]
This update reports completion of Phase 1/2 trials evaluating healing with the COMBO Stent using OCT imaging.
-
CLINICAL_TRIALS trial_result · 2013-02-26Clinical Trial Update: Optical Coherence Tomography to Evaluate Paclitaxel-Eluting Balloons and Everolimus-Eluting Coronary Stents [Phase 4]
Phase 4 trial evaluating paclitaxel-eluting balloons and everolimus-eluting coronary stents using optical coherence tomography; the study ha…
-
CLINICAL_TRIALS trial_result · 2012-12-24Clinical Trial Update: The SCRIPPS DES REAL WORLD Registry
The SCRIPPS DES REAL WORLD Registry clinical trial, sponsored by Paul S Teirstein, MD, has completed, involving coronary artery disease, cor…
-
CLINICAL_TRIALS trial_result · 2012-12-04Clinical Trial Update: EXCEL Clinical Trial (Universal Registry)
An update indicating the EXCEL trial comparing PCI with everolimus-eluting stents to CABG for left main coronary artery disease has complete…
-
CLINICAL_TRIALS trial_result · 2012-09-06Clinical Trial Update: Clinical Evaluation of Patients With Everolimus-eluting Stent Xience V® Implanted in the Treatment of Restenosis in Non-coated Metallic Stent (BMS In-stent Restenosis) During a 2 Year Clinical Follow-up Period [Phase 3]
Phase 3 study evaluating the safety and efficacy of the everolimus-eluting Xience V stent for treating in-stent restenosis of a bare-metal s…
-
CLINICAL_TRIALS trial_result · 2012-08-14Clinical Trial Update: XIENCE V® Everolimus Eluting Coronary Stent System India Post-marketing Single-arm Study
A post-marketing, single-arm clinical study in India evaluating the XIENCE V Everolimus-eluting coronary stent system has completed.
-
CLINICAL_TRIALS trial_result · 2012-07-13Clinical Trial Update: XIENCE V: SPIRIT WOMEN Sub-study [Phase 4]
Phase 4 SPIRIT WOMEN sub-study updating results for the XIENCE V everolimus-eluting coronary stent; the study completed with results posted …
-
CLINICAL_TRIALS trial_result · 2012-06-01Clinical Trial Update: SPIRIT PRIME Clinical Trial [Phase 3]
Abbott Medical Devices has completed and posted results for the SPIRIT PRIME Phase 3 clinical trial.
-
CLINICAL_TRIALS trial_result · 2012-03-08Clinical Trial Update: Use of Nanoparticle Paclitaxel (ABI-007) for the Prevention of In-Stent Restenosis [Phase 1, Phase 2]
A Phase 1/2 trial evaluating ABI-007, a nanoparticle paclitaxel formulation, for prevention of in-stent restenosis in coronary arteries; the…